These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19429730)

  • 21. Prostate cancer in the elderly.
    Heinzer H; Steuber T
    Urol Oncol; 2009; 27(6):668-72. PubMed ID: 19879477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Quality of life after biochemical recurrence in patients with prostate cancer. How and how long do patients live after biochemical recurrence?].
    Caamaño AG; Mateos LL; Fernández EF; Crespo PC; Valladares BT; Higuero PP; Castro AC
    Arch Esp Urol; 2012; 65(1):193-206. PubMed ID: 22318190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural course of localized prostate cancer. a personal view with a review of published papers.
    Hugosson J; Aus G
    Anticancer Res; 1997; 17(3A):1441-8. PubMed ID: 9179181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer.
    Hall WH; Jani AB; Ryu JK; Narayan S; Vijayakumar S
    Prostate Cancer Prostatic Dis; 2005; 8(1):22-30. PubMed ID: 15700051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
    Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance.
    Latini DM; Hart SL; Knight SJ; Cowan JE; Ross PL; Duchane J; Carroll PR;
    J Urol; 2007 Sep; 178(3 Pt 1):826-31; discussion 831-2. PubMed ID: 17632144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of localized prostate cancer in senior adults: the crucial role of comorbidity.
    Fitzpatrick JM
    BJU Int; 2008 Mar; 101 Suppl 2():16-22. PubMed ID: 18307688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts.
    Malaeb BS; Rashid HH; Lotan Y; Khoddami SM; Shariat SF; Sagalowsky AI; McConnell JD; Roehrborn CG; Koeneman KS
    Urol Oncol; 2007; 25(4):291-7. PubMed ID: 17628294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conservative management of prostate cancer in the prostate specific antigen era: the incidence and time course of subsequent therapy.
    Zietman AL; Thakral H; Wilson L; Schellhammer P
    J Urol; 2001 Nov; 166(5):1702-6. PubMed ID: 11586206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regret in men treated for localized prostate cancer.
    Hu JC; Kwan L; Saigal CS; Litwin MS
    J Urol; 2003 Jun; 169(6):2279-83. PubMed ID: 12771770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
    Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
    BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Place of surveillance in the treatment of localized prostate cancer].
    Ravery V; Boccon-Gibod L
    Prog Urol; 1999 Apr; 9(2):225-30; discussion 229-30. PubMed ID: 10370945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comorbid survival among elderly male participants of the Canada health survey: relevance to prostate cancer screening and treatment.
    Eapen L; Villeneuve PJ; Levy IG; Morrison HI
    Chronic Dis Can; 1998; 19(3):84-90. PubMed ID: 9820831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of older men with clinically localized prostate cancer: the significance of advanced age and comorbidity.
    Hoffman KE
    Semin Radiat Oncol; 2012 Oct; 22(4):284-94. PubMed ID: 22985811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes following active surveillance of men with localized prostate cancer diagnosed in the prostate specific antigen era.
    Ercole B; Marietti SR; Fine J; Albertsen PC
    J Urol; 2008 Oct; 180(4):1336-9; discussion 1340-1. PubMed ID: 18707696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate cancer incidence and survival in relation to education (United States).
    Steenland K; Rodriguez C; Mondul A; Calle EE; Thun M
    Cancer Causes Control; 2004 Nov; 15(9):939-45. PubMed ID: 15577296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
    Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR
    BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate cancer.
    Tendulkar RD; Hunter GK; Reddy CA; Stephans KL; Ciezki JP; Abdel-Wahab M; Stephenson AJ; Klein EA; Mahadevan A; Kupelian PA
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):94-9. PubMed ID: 23920389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate cancer. Mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment.
    Aus G
    Scand J Urol Nephrol Suppl; 1994; 167():1-41. PubMed ID: 7542397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate cancer in the senior men from rural areas in east district of China: contemporary management and 5-year outcomes at multi-institutional collaboration.
    Shao Q; Ouyang J; Fan Y; Xie J; Zhou J; Wu J; Karim Kader A; Xu J; Liu G; Shan Y; Wen D; Zhang Y
    Cancer Lett; 2012 Feb; 315(2):170-7. PubMed ID: 22099876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.